Investigational small molecules in phase II clinical trials for the treatment of epilepsy. [electronic resource]
- Expert opinion on investigational drugs 12 2018
- 971-979 p. digital
Publication Type: Journal Article; Review
1744-7658
10.1080/13543784.2018.1543398 doi
Animals Anticonvulsants--pharmacology Cannabinoids--pharmacology Clinical Trials, Phase II as Topic Drug Design Drug Resistant Epilepsy--drug therapy Drugs, Investigational--pharmacology Epilepsy--drug therapy Humans Pregnanolone--analogs & derivatives Quality of Life Quinazolinones--pharmacology